Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Scheinberg

Showing results (91-100 of 121) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxideL H Camacho, S L Soignet, S Chanel, et al.
Leukemia|July 27, 2017
CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopesM D Mathias, J T Sockolosky, A Y Chang, et al.
European Journal of Nuclear Medicine|September 2, 1998
Radioimmunotherapy with alpha-emitting nuclidesM R McDevitt, G Sgouros, R D Finn, et al.
Leukemia|September 23, 2006
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoproteinJ Pinilla-Ibarz, R J May, T Korontsvit, et al.
Leukemia|February 13, 2002
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodiesD Ma, M R McDevitt, E Barendswaard, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Physics in Medicine and Biology|January 12, 2011
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibodyJ Schwartz, J S Jaggi, J A O'Donoghue, et al.
Synapse (New York, N.Y.)|October 19, 1999
[(125)I]orphanin FQ/nociceptin binding in Raji cellsJ S Hom, I Goldberg, J Mathis, et al.
Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Pageof 13

Showing results (91-100 of 121) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2000
Leukocytosis and the retinoic acid syndrome in patients with acute promyelocytic leukemia treated with arsenic trioxideL H Camacho, S L Soignet, S Chanel, et al.
Leukemia|July 27, 2017
CD47 blockade enhances therapeutic activity of TCR mimic antibodies to ultra-low density cancer epitopesM D Mathias, J T Sockolosky, A Y Chang, et al.
European Journal of Nuclear Medicine|September 2, 1998
Radioimmunotherapy with alpha-emitting nuclidesM R McDevitt, G Sgouros, R D Finn, et al.
Leukemia|September 23, 2006
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoproteinJ Pinilla-Ibarz, R J May, T Korontsvit, et al.
Leukemia|February 13, 2002
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodiesD Ma, M R McDevitt, E Barendswaard, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Physics in Medicine and Biology|January 12, 2011
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibodyJ Schwartz, J S Jaggi, J A O'Donoghue, et al.
Synapse (New York, N.Y.)|October 19, 1999
[(125)I]orphanin FQ/nociceptin binding in Raji cellsJ S Hom, I Goldberg, J Mathis, et al.
Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.
Blood|February 26, 2000
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responsesJ Pinilla-Ibarz, K Cathcart, T Korontsvit, et al.
Pageof 13